Previous 10 | Next 10 |
MINNEAPOLIS, July 02, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the “Company” or “Panbela”), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced the clo...
Gainers: Ocuphire Pharma (OCUP) +26%, Predictive Oncology (POAI) +21%, Verve Therapeutics (VERV) +21%, HUTCHMED (China) (HCM) +21%, Intellia Therapeutics (NTLA) +19%.Losers: Altimmune (ALT) -36%, electroCore (ECOR) -28%,...
Altimmune (ALT) -33% Altimmune to scrap COVID-19 vaccine program after "disappointing" results.Panbela Therapeutics (PBLA) -26% after secures $10M capital raiseMarin Software (MRIN) -20%.Check-Cap (CHEK) -17% after announcing $35M registered direct offering.Qumu (QUMU...
Panbela Therapeutics' (PBLA) underwriter has agreed to increase the size of the previous public offering and purchase ~3.3M common shares at $3.00/share.Expected gross proceeds are ~$10M. Underwriter's over-allotment is an additional 500K shares. Net proceeds will be used for the continued cl...
MINNEAPOLIS, June 30, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the “Company” or “Panbela”), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that, d...
Panbela Therapeutics ([[PBLA]] -6.1%) announced a $5M bought deal offering of its common stock by H.C. Wainwright.H.C. Wainwright will buy 1,666,667 shares at a price of $3 per share.The closing is expected on July 2.H.C. Wainwright also has the option of purchasing an additional 250K sh...
MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the “Company” or “Panbela”), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that it...
Intellia Therapeutics (NTLA) +58%. after releasing interim data from a phase 1 trial of a CRISPR candidate.Marin Software Incorporated (MRIN) +38%.ReShape Lifesciences (RSLS) +34%.Anavex Life Sciences (AVXL) +24% after after ANAVEX2-73 improved endpoints in Phase 2 Parkinson’s dis...
RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified investors throughout the thr...
Panbela Therapeutics ([[PBLA]]) is set to be added to Russell Microcap Index at the conclusion of the Russell US Indexes annual reconstitution, effective opening of the equity markets on June 28.“We look forward to the opportunity to communicate our strate...
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
Panbela Therapeutics Inc Com Website:
DSMB Recommends Continuation without Modification for Third Time Safety Review Included 395 Patients Interim Survival Analysis Still Expected Early 2025 given Lower-Than-Expected Event Rate Low Event Rate Suggests Potential for Prolonged Survival Rapid Enrollment P...
MINNEAPOLIS, June 10, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (OTCQB: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announces an oral presentation at the Digestive Disease Week (DDW) conference,...
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the q...